← Back to Screener
Rocket Pharmaceuticals, Inc. Warrant (RCKTW)
Price$0.01
Favorite Metrics
Price vs S&P 500 (26W)-83.43%
Price vs S&P 500 (4W)-46.84%
All Metrics
Price vs S&P 500 (YTD)-61.57%
10-Day Avg Trading Volume0.03M
3-Month Avg Trading Volume0.03M
52-Week High$0.09
26-Week Price Return-74.68%
13-Week Price Return-35.29%
3-Month Return Std Dev222.88%
Year-to-Date Return-59.26%
5-Day Price Return-1.00%
Month-to-Date Return-51.94%
Price vs S&P 500 (13W)-38.16%
Beta3.04x
52-Week Low$0.01
Industry Peers — Pharmaceuticals(309)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
RCKTWRocket Pharmaceuticals, Inc. Warrant | — | — | — | — | $0.01 |
LLYEli Lilly & Co. | 13.45x | 44.70% | 83.04% | 27.59% | $919.90 |
JNJJohnson & Johnson | 5.82x | 7.87% | 67.95% | 14.90% | $230.69 |
ABBVABBVIE INC. | 5.97x | 8.57% | 71.62% | -2.88% | $203.71 |
MRKMerck & Co., Inc. | 4.51x | 1.31% | 78.55% | 21.23% | $117.10 |
AZNAstraZeneca PLC | 5.39x | 8.63% | 81.31% | 21.88% | $200.69 |
NVSNovartis AG | 4.87x | 8.91% | 75.82% | 15.26% | $150.99 |
NVONovo-Nordisk A/S | 3.74x | 6.43% | 80.98% | 20.66% | $40.46 |
ABTAbbott Laboratories | 3.71x | 6.59% | 56.50% | 8.20% | $96.00 |
PFEPfizer Inc. | 2.50x | -1.64% | 75.81% | -3.51% | $27.52 |
BMYBristol-Myers Squibb Co. | 2.52x | -0.22% | 72.63% | — | $59.13 |
About
Rocket Pharmaceuticals is a late-stage biopharmaceutical company developing gene therapies for rare pediatric diseases. Its pipeline includes five clinical and preclinical programs targeting Fanconi Anemia, Leukocyte Adhesion Deficiency, Pyruvate Kinase Deficiency, Danaon Disease, and Infantile Malignant Osteopetrosis. The company focuses on research, development, and commercialization of its gene therapy candidates.